Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cy A Stein

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical Genitourinary Cancer|June 30, 2015
Treatment Sequencing in Metastatic Castration-Resistant Prostate Cancer: A Clinical CommentaryCy A Stein
Nucleic Acid Therapeutics|June 26, 2024
Phosphorothioates and Me: A Lecture About My 35 Years in Oligo-World on My Receipt of the 2023 Lifetime Achievement Award of the Oligonucleotide Therapeutics SocietyCy A Stein
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 6, 2016
Eteplirsen Approved for Duchenne Muscular Dystrophy: The FDA Faces a Difficult ChoiceCy A Stein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2011
Therapeutic oligonucleotides: the road not takenCy A Stein, Sanjay Goel
Current Opinion in Oncology|September 5, 2014
Antisense oligonucleotides in cancerDaniela Castanotto, Cy A Stein
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2017
FDA-Approved Oligonucleotide Therapies in 2017Cy A Stein, Daniela Castanotto
Clinical Genitourinary Cancer|May 12, 2012
Prolonged therapy with cabazitaxel in an octogenarian with metastatic castration-resistant prostate cancerSumanta K Pal, Cy A Stein
Expert Opinion on Pharmacotherapy|February 28, 2013
Enzalutamide for the treatment of prostate cancerSumanta K Pal, Cy A Stein, Oliver Sartor
Expert Opinion on Investigational Drugs|April 30, 2013
Targeting angiopoietin-2 signaling in cancer therapyZeynep Eroglu, Cy A Stein, Sumanta K Pal
Trends in Pharmacological Sciences|December 15, 2019
Oligonucleotides to the (Gene) Rescue: FDA Approvals 2017-2019Jacqueline Rüger, Silvia Ioannou, Daniela Castanotto, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical Genitourinary Cancer|June 30, 2015
Treatment Sequencing in Metastatic Castration-Resistant Prostate Cancer: A Clinical CommentaryCy A Stein
Nucleic Acid Therapeutics|June 26, 2024
Phosphorothioates and Me: A Lecture About My 35 Years in Oligo-World on My Receipt of the 2023 Lifetime Achievement Award of the Oligonucleotide Therapeutics SocietyCy A Stein
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 6, 2016
Eteplirsen Approved for Duchenne Muscular Dystrophy: The FDA Faces a Difficult ChoiceCy A Stein
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2011
Therapeutic oligonucleotides: the road not takenCy A Stein, Sanjay Goel
Current Opinion in Oncology|September 5, 2014
Antisense oligonucleotides in cancerDaniela Castanotto, Cy A Stein
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2017
FDA-Approved Oligonucleotide Therapies in 2017Cy A Stein, Daniela Castanotto
Clinical Genitourinary Cancer|May 12, 2012
Prolonged therapy with cabazitaxel in an octogenarian with metastatic castration-resistant prostate cancerSumanta K Pal, Cy A Stein
Expert Opinion on Pharmacotherapy|February 28, 2013
Enzalutamide for the treatment of prostate cancerSumanta K Pal, Cy A Stein, Oliver Sartor
Expert Opinion on Investigational Drugs|April 30, 2013
Targeting angiopoietin-2 signaling in cancer therapyZeynep Eroglu, Cy A Stein, Sumanta K Pal
Trends in Pharmacological Sciences|December 15, 2019
Oligonucleotides to the (Gene) Rescue: FDA Approvals 2017-2019Jacqueline Rüger, Silvia Ioannou, Daniela Castanotto, et al.
Pageof 3